ID   AATC_HUMAN              Reviewed;         413 AA.
AC   P17174; B2R6R7; B7Z7E9; Q5VW80;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   12-APR-2017, entry version 178.
DE   RecName: Full=Aspartate aminotransferase, cytoplasmic;
DE            Short=cAspAT;
DE            EC=2.6.1.1;
DE            EC=2.6.1.3;
DE   AltName: Full=Cysteine aminotransferase, cytoplasmic;
DE   AltName: Full=Cysteine transaminase, cytoplasmic;
DE            Short=cCAT;
DE   AltName: Full=Glutamate oxaloacetate transaminase 1;
DE   AltName: Full=Transaminase A;
GN   Name=GOT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION.
RC   TISSUE=Liver;
RX   PubMed=1974457; DOI=10.1021/bi00474a011;
RA   Bousquet-Lemercier B., Pol S., Pave-Preux M., Hanoune J., Barouki R.;
RT   "Properties of human liver cytosolic aspartate aminotransferase mRNAs
RT   generated by alternative polyadenylation site selection.";
RL   Biochemistry 29:5293-5299(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Wang C.Y., Huang Y.Q., Shi J.D., Marron M.P., Ruan Q.G.,
RA   Hawkins-Lee B., Ochoa B., She J.X.;
RT   "Genomic structure and mutation analysis of GOT1 in the urofacial
RT   (Ochoa) syndrome gene critical region on chromosome 10.";
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Yu W., Sarginson J., Gibbs R.A.;
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-413.
RC   TISSUE=Liver;
RX   PubMed=2241899; DOI=10.1042/bj2700651;
RA   Doyle J.M., Schinina M.E., Bossa F., Doonan S.;
RT   "The amino acid sequence of cytosolic aspartate aminotransferase from
RT   human liver.";
RL   Biochem. J. 270:651-657(1990).
RN   [9]
RP   FUNCTION.
RX   PubMed=16039064; DOI=10.1016/j.neulet.2005.06.030;
RA   D'Aniello A., Fisher G., Migliaccio N., Cammisa G., D'Aniello E.,
RA   Spinelli P.;
RT   "Amino acids and transaminases activity in ventricular CSF and in
RT   brain of normal and Alzheimer patients.";
RL   Neurosci. Lett. 388:49-53(2005).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   INVOLVEMENT IN ASTQTL1, VARIANT ASN-389 DEL, CHARACTERIZATION OF
RP   VARIANT ASN-389 DEL, AND POLYMORPHISM.
RX   PubMed=21900944; DOI=10.1038/jhg.2011.105;
RA   Shen H., Damcott C., Shuldiner S.R., Chai S., Yang R., Hu H.,
RA   Gibson Q., Ryan K.A., Mitchell B.D., Gong D.W.;
RT   "Genome-wide association study identifies genetic variants in GOT1
RT   determining serum aspartate aminotransferase levels.";
RL   J. Hum. Genet. 56:801-805(2011).
RN   [12]
RP   FETAL BLOOD LEVELS.
RX   PubMed=22633534; DOI=10.1016/j.earlhumdev.2012.05.001;
RA   Zlotnik A., Tsesis S., Gruenbaum B.F., Ohayon S., Gruenbaum S.E.,
RA   Boyko M., Sheiner E., Brotfain E., Shapira Y., Teichberg V.I.;
RT   "Relationship between glutamate, GOT and GPT levels in maternal and
RT   fetal blood: a potential mechanism for fetal neuroprotection.";
RL   Early Hum. Dev. 88:773-778(2012).
RN   [13]
RP   CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 14-412 IN COMPLEX WITH
RP   PYRIDOXAL PHOSPHATE AND TARTARIC ACID, SUBUNIT, AND PYRIDOXAL
RP   PHOSPHATE AT LYS-259.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human glutamate oxaloacetate transaminase 1
RT   (GOT1).";
RL   Submitted (AUG-2009) to the PDB data bank.
CC   -!- FUNCTION: Biosynthesis of L-glutamate from L-aspartate or L-
CC       cysteine. Important regulator of levels of glutamate, the major
CC       excitatory neurotransmitter of the vertebrate central nervous
CC       system. Acts as a scavenger of glutamate in brain neuroprotection.
CC       The aspartate aminotransferase activity is involved in hepatic
CC       glucose synthesis during development and in adipocyte
CC       glyceroneogenesis. Using L-cysteine as substrate, regulates levels
CC       of mercaptopyruvate, an important source of hydrogen sulfide.
CC       Mercaptopyruvate is converted into H(2)S via the action of 3-
CC       mercaptopyruvate sulfurtransferase (3MST). Hydrogen sulfide is an
CC       important synaptic modulator and neuroprotectant in the brain.
CC       {ECO:0000269|PubMed:16039064}.
CC   -!- CATALYTIC ACTIVITY: L-aspartate + 2-oxoglutarate = oxaloacetate +
CC       L-glutamate.
CC   -!- CATALYTIC ACTIVITY: L-cysteine + 2-oxoglutarate = mercaptopyruvate
CC       + L-glutamate.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|Ref.16}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:1974457}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P17174-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P17174-2; Sequence=VSP_055799;
CC         Note=No experimental confirmation available.;
CC   -!- POLYMORPHISM: Genetic variations in GOT1 are associated with low
CC       serum aspartate aminotransferase and define the aspartate
CC       aminotransferase serum level quantitative trait locus 1 (ASTQTL1)
CC       [MIM:614419]. {ECO:0000269|PubMed:21900944}.
CC   -!- MISCELLANEOUS: In eukaryotes there are cytoplasmic, mitochondrial
CC       and chloroplastic isozymes.
CC   -!- MISCELLANEOUS: Aspartate aminotransferase activity found to be
CC       increased in cerebral spinal fluid (CSF) of patients with
CC       Alzheimer disease (PubMed:16039064). Fetal serum levels of the
CC       enzyme in the umbilical artery and vein are found to be
CC       significantly higher than maternal serum levels (PubMed:22633534).
CC       {ECO:0000305|PubMed:16039064, ECO:0000305|PubMed:22633534}.
CC   -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M37400; AAA35563.1; -; mRNA.
DR   EMBL; AF080467; AAC32851.1; -; Genomic_DNA.
DR   EMBL; AF080459; AAC32851.1; JOINED; Genomic_DNA.
DR   EMBL; AF080460; AAC32851.1; JOINED; Genomic_DNA.
DR   EMBL; AF080461; AAC32851.1; JOINED; Genomic_DNA.
DR   EMBL; AF080462; AAC32851.1; JOINED; Genomic_DNA.
DR   EMBL; AF080463; AAC32851.1; JOINED; Genomic_DNA.
DR   EMBL; AF080464; AAC32851.1; JOINED; Genomic_DNA.
DR   EMBL; AF080465; AAC32851.1; JOINED; Genomic_DNA.
DR   EMBL; AF080466; AAC32851.1; JOINED; Genomic_DNA.
DR   EMBL; AF052153; AAC28622.1; -; mRNA.
DR   EMBL; AK301916; BAH13585.1; -; mRNA.
DR   EMBL; AK312684; BAG35564.1; -; mRNA.
DR   EMBL; AL391684; CAH73859.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49869.1; -; Genomic_DNA.
DR   EMBL; BC000498; AAH00498.1; -; mRNA.
DR   CCDS; CCDS7479.1; -. [P17174-1]
DR   PIR; S13035; S13035.
DR   PIR; S29027; S29027.
DR   RefSeq; NP_002070.1; NM_002079.2. [P17174-1]
DR   UniGene; Hs.500756; -.
DR   PDB; 3II0; X-ray; 2.05 A; A/B/C/D=14-412.
DR   PDB; 3WZF; X-ray; 2.99 A; A=2-413.
DR   PDBsum; 3II0; -.
DR   PDBsum; 3WZF; -.
DR   ProteinModelPortal; P17174; -.
DR   SMR; P17174; -.
DR   BioGrid; 109067; 58.
DR   IntAct; P17174; 3.
DR   MINT; MINT-5002473; -.
DR   STRING; 9606.ENSP00000359539; -.
DR   ChEMBL; CHEMBL2189139; -.
DR   DrugBank; DB00128; L-Aspartic Acid.
DR   DrugBank; DB00151; L-Cysteine.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB04299; Maleic Acid.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   iPTMnet; P17174; -.
DR   PhosphoSitePlus; P17174; -.
DR   SwissPalm; P17174; -.
DR   BioMuta; GOT1; -.
DR   DMDM; 5902703; -.
DR   REPRODUCTION-2DPAGE; IPI00219029; -.
DR   UCD-2DPAGE; P17174; -.
DR   EPD; P17174; -.
DR   MaxQB; P17174; -.
DR   PaxDb; P17174; -.
DR   PeptideAtlas; P17174; -.
DR   PRIDE; P17174; -.
DR   Ensembl; ENST00000370508; ENSP00000359539; ENSG00000120053. [P17174-1]
DR   GeneID; 2805; -.
DR   KEGG; hsa:2805; -.
DR   UCSC; uc001kpr.4; human. [P17174-1]
DR   CTD; 2805; -.
DR   DisGeNET; 2805; -.
DR   GeneCards; GOT1; -.
DR   HGNC; HGNC:4432; GOT1.
DR   HPA; HPA064532; -.
DR   HPA; HPA072629; -.
DR   MalaCards; GOT1; -.
DR   MIM; 138180; gene.
DR   MIM; 614419; phenotype.
DR   neXtProt; NX_P17174; -.
DR   OpenTargets; ENSG00000120053; -.
DR   PharmGKB; PA28817; -.
DR   eggNOG; KOG1411; Eukaryota.
DR   eggNOG; COG1448; LUCA.
DR   GeneTree; ENSGT00390000014081; -.
DR   HOGENOM; HOG000185898; -.
DR   HOVERGEN; HBG000951; -.
DR   InParanoid; P17174; -.
DR   KO; K14454; -.
DR   OMA; PNHKGVF; -.
DR   OrthoDB; EOG091G06G3; -.
DR   PhylomeDB; P17174; -.
DR   TreeFam; TF314089; -.
DR   BioCyc; MetaCyc:HS04361-MONOMER; -.
DR   Reactome; R-HSA-1237112; Methionine salvage pathway.
DR   Reactome; R-HSA-70263; Gluconeogenesis.
DR   Reactome; R-HSA-70614; Amino acid synthesis and interconversion (transamination).
DR   SABIO-RK; P17174; -.
DR   ChiTaRS; GOT1; human.
DR   EvolutionaryTrace; P17174; -.
DR   GeneWiki; GOT1; -.
DR   GenomeRNAi; 2805; -.
DR   PRO; PR:P17174; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000120053; -.
DR   CleanEx; HS_GOT1; -.
DR   ExpressionAtlas; P17174; baseline and differential.
DR   Genevisible; P17174; HS.
DR   GO; GO:0043679; C:axon terminus; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031406; F:carboxylic acid binding; IEA:Ensembl.
DR   GO; GO:0004069; F:L-aspartate:2-oxoglutarate aminotransferase activity; IDA:UniProtKB.
DR   GO; GO:0047801; F:L-cysteine:2-oxoglutarate aminotransferase activity; ISS:UniProtKB.
DR   GO; GO:0080130; F:L-phenylalanine:2-oxoglutarate aminotransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004609; F:phosphatidylserine decarboxylase activity; IEA:Ensembl.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; ISS:UniProtKB.
DR   GO; GO:0006532; P:aspartate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006533; P:aspartate catabolic process; IDA:UniProtKB.
DR   GO; GO:0006531; P:aspartate metabolic process; ISS:UniProtKB.
DR   GO; GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:UniProtKB.
DR   GO; GO:0055089; P:fatty acid homeostasis; IEA:Ensembl.
DR   GO; GO:0006094; P:gluconeogenesis; TAS:Reactome.
DR   GO; GO:0019551; P:glutamate catabolic process to 2-oxoglutarate; IEA:Ensembl.
DR   GO; GO:0019550; P:glutamate catabolic process to aspartate; IEA:Ensembl.
DR   GO; GO:0006536; P:glutamate metabolic process; ISS:UniProtKB.
DR   GO; GO:0006114; P:glycerol biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:0006107; P:oxaloacetate metabolic process; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:UniProtKB.
DR   Gene3D; 3.90.1150.10; -; 2.
DR   InterPro; IPR004839; Aminotransferase_I/II.
DR   InterPro; IPR000796; Asp_trans.
DR   InterPro; IPR004838; NHTrfase_class1_PyrdxlP-BS.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_sub2.
DR   PANTHER; PTHR11879; PTHR11879; 1.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   PRINTS; PR00799; TRANSAMINASE.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   PROSITE; PS00105; AA_TRANSFER_CLASS_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Amino-acid biosynthesis;
KW   Aminotransferase; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Phosphoprotein; Polymorphism;
KW   Pyridoxal phosphate; Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|PubMed:2241899}.
FT   CHAIN         2    413       Aspartate aminotransferase, cytoplasmic.
FT                                /FTId=PRO_0000123879.
FT   BINDING      39     39       Aspartate; via amide nitrogen.
FT   BINDING     141    141       Aspartate.
FT   BINDING     195    195       Aspartate.
FT   BINDING     387    387       Aspartate.
FT   MOD_RES     149    149       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P13221}.
FT   MOD_RES     259    259       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1     39       MAPPSVFAEVPQAQPVLVFKLTADFREDPDPRKVNLGVG
FT                                -> MQVWSPWKGAMCPRPHKP (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055799.
FT   VARIANT     389    389       Missing (results in markedly diminished
FT                                enzymatic activity).
FT                                {ECO:0000269|PubMed:21900944}.
FT                                /FTId=VAR_067256.
FT   CONFLICT    215    215       H -> R (in Ref. 8; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND        6      9       {ECO:0000244|PDB:3WZF}.
FT   HELIX        17     27       {ECO:0000244|PDB:3II0}.
FT   HELIX        52     62       {ECO:0000244|PDB:3II0}.
FT   HELIX        78     89       {ECO:0000244|PDB:3II0}.
FT   HELIX        94     97       {ECO:0000244|PDB:3II0}.
FT   STRAND      101    107       {ECO:0000244|PDB:3II0}.
FT   HELIX       108    123       {ECO:0000244|PDB:3II0}.
FT   STRAND      124    128       {ECO:0000244|PDB:3II0}.
FT   STRAND      134    139       {ECO:0000244|PDB:3II0}.
FT   HELIX       143    150       {ECO:0000244|PDB:3II0}.
FT   STRAND      156    160       {ECO:0000244|PDB:3II0}.
FT   TURN        164    167       {ECO:0000244|PDB:3II0}.
FT   HELIX       171    179       {ECO:0000244|PDB:3II0}.
FT   STRAND      186    190       {ECO:0000244|PDB:3II0}.
FT   TURN        195    197       {ECO:0000244|PDB:3II0}.
FT   HELIX       203    216       {ECO:0000244|PDB:3II0}.
FT   STRAND      219    225       {ECO:0000244|PDB:3II0}.
FT   TURN        227    231       {ECO:0000244|PDB:3II0}.
FT   HELIX       234    237       {ECO:0000244|PDB:3II0}.
FT   HELIX       239    246       {ECO:0000244|PDB:3II0}.
FT   STRAND      251    256       {ECO:0000244|PDB:3II0}.
FT   TURN        258    261       {ECO:0000244|PDB:3II0}.
FT   HELIX       264    266       {ECO:0000244|PDB:3II0}.
FT   STRAND      268    274       {ECO:0000244|PDB:3II0}.
FT   HELIX       278    293       {ECO:0000244|PDB:3II0}.
FT   TURN        294    296       {ECO:0000244|PDB:3II0}.
FT   HELIX       302    311       {ECO:0000244|PDB:3II0}.
FT   HELIX       314    344       {ECO:0000244|PDB:3II0}.
FT   HELIX       352    356       {ECO:0000244|PDB:3II0}.
FT   STRAND      359    363       {ECO:0000244|PDB:3II0}.
FT   HELIX       368    378       {ECO:0000244|PDB:3II0}.
FT   TURN        384    386       {ECO:0000244|PDB:3WZF}.
FT   STRAND      387    389       {ECO:0000244|PDB:3II0}.
FT   HELIX       390    392       {ECO:0000244|PDB:3II0}.
FT   TURN        395    397       {ECO:0000244|PDB:3II0}.
FT   HELIX       398    411       {ECO:0000244|PDB:3II0}.
SQ   SEQUENCE   413 AA;  46248 MW;  69FE68BF0C045219 CRC64;
     MAPPSVFAEV PQAQPVLVFK LTADFREDPD PRKVNLGVGA YRTDDCHPWV LPVVKKVEQK
     IANDNSLNHE YLPILGLAEF RSCASRLALG DDSPALKEKR VGGVQSLGGT GALRIGADFL
     ARWYNGTNNK NTPVYVSSPT WENHNAVFSA AGFKDIRSYR YWDAEKRGLD LQGFLNDLEN
     APEFSIVVLH ACAHNPTGID PTPEQWKQIA SVMKHRFLFP FFDSAYQGFA SGNLERDAWA
     IRYFVSEGFE FFCAQSFSKN FGLYNERVGN LTVVGKEPES ILQVLSQMEK IVRITWSNPP
     AQGARIVAST LSNPELFEEW TGNVKTMADR ILTMRSELRA RLEALKTPGT WNHITDQIGM
     FSFTGLNPKQ VEYLVNEKHI YLLPSGRINV SGLTTKNLDY VATSIHEAVT KIQ
//
